| Literature DB >> 29306402 |
Ryan P Hillary1, Hanna M Ollila1, Ling Lin1, Virginie Desestret2, Veronique Rogemond2, Geraldine Picard2, Mathilde Small2, Isabelle Arnulf3, Yves Dauvilliers4, Jerome Honnorat5, Emmanuel Mignot6.
Abstract
Anti-Yo paraneoplastic cerebellar degeneration (PCD) is a devastating autoimmune complication of gynecological cancers. We hypothesized that as for other autoimmune diseases, specific HLA haplotypes are associated. We conducted high resolution HLA typing of Class I/Class II in 40 cases versus ethnically matched controls. Three cases with anti-Yo antibodies and peripheral neuropathy were also included. We detected protective effects of DPA1*01:03~DPB1*04:01 (OR=0, p=0.0008), DRB1*04:01~DQA1*03:03(OR=0, p=0.0016) and DPA1*01:03~DPB1*04:01 (OR=0.35, p=0.0047) overall. Increased DRB1*13:01~DQA1*01:03~DQB1*06:03 was also found in PCD ovarian cases (OR=5.4, p=0.0016). These results suggest differential genetic susceptibility to anti-Yo per cancer and with a primary HLA Class II involvement.Entities:
Keywords: Anti-Yo; Ataxia; Breast cancer; Ovarian cancer; Paraneoplastic
Mesh:
Substances:
Year: 2017 PMID: 29306402 DOI: 10.1016/j.jneuroim.2017.12.012
Source DB: PubMed Journal: J Neuroimmunol ISSN: 0165-5728 Impact factor: 3.478